Table2 Difference of clinical data before operation between cervical OPLL positive and negative patients

From: To infer the probability of cervical ossification of the posterior longitudinal ligament and explore its impact on cervical surgery

Type

Training cohort

Validation cohort

OPLL positive (N=107)

OPLL negative (N=509)

P-value

OPLL positive (N=37)

OPLL negative (N=122)

P-value

OALL

      

Positive

29(27.1%)

35(6.9%)

<0.001

14(37.8%)

16(13.1%)

0.001

Negative

78(72.9%)

474(93.1%)

 

23(62.2%)

106(86.9%)

 

Gender

Male

38(35.5%)

291(57.2%)

<0.001

22(59.5%)

78(64%)

0.379

Female

69(64.5%)

218(42.8%)

 

15(40.5%)

44(36%)

 

hs-CRP

<0.8

31(29%)

182(35.8%)

0.317

18(48.6%)

47(38.5%)

0.539

0.8-10

48(44.9%)

220(43.2%)

 

13(35.1%)

53(43.4%)

 

>10

28(26.1%)

107(21%)

 

6(16.2)

22(18.1%)

 

Age

Mean

56.8

54.48

0.035

56.92

55.38

0.438

BMI(kg/m2)

Mean

24.2

23.24

0.004

23.5

23.45

0.919

Emergency admission

Yes

2(1.9%)

5(1%)

0.35

1(2.7%)

2(1.6%)

0.551

No

105(98.1%)

504(99%)

 

36(96.3%)

120(98.4%)

 

Classification of neural function

3

46(43%)

199(39.1%)

0.26

15(40.5%)

45(36.9%)

0.414

4

61(57%)

310(60.9%)

 

22(59.5%)

77(63.1%)

 

History of cervical spine surgery

Yes

10(9.3%)

23(4.5%)

0.044

6(16.2%)

5(4.1%)

0.02

No

97(90.7%)

486(95.5%)

 

31(83.8%)

117(95.9%)

 

Cervical instability

Yes

18(16.8%)

75(14.7%)

0.338

4(10.8%)

12(9.8%)

0.537

No

89(83.2%)

434(85.3%)

 

33(89.2%)

110(90.2%)

 

Diabetes

Yes

9(8.4%)

24(4.7%)

0.1

2(5.4%)

9(7.4%)

0.506

No

98(91.6%)

485(95.3%)

 

35(94.6%)

113(92.6%)

 

Hypertension

Yes

29(27.1%)

78(15.3%)

0.004

3(8.1%)

26(21.3%)

0.051

No

78(72.9%)

431(84.7%)

 

34(91.9%)

96(78.7%)

 

CHD

Yes

3(3%)

2(0.4%)

0.039

1(3%)

1(0.8%)

0.412

No

104(97%)

507(99.6%)

 

36(97%)

121(99.2%)

 

Abnormal liver and kidney function

Yes

3(3%)

3(0.6%)

0.412

0(0%)

2(1.6%)

0.588

No

104(97%)

506(99.4%)

 

37(100%)

120(98.4%)

 

Cerebrovascular Disease

Yes

3(3%)

13(2.6%)

0.546

1(3%)

1(0.8%)

0.412

No

104(97%)

496(97.4)

 

36(97%)

121(99.2%)

 

Peptic ulcer

Yes

5(4.7%)

27(5.3%)

0.508

0(0%)

1(0.8%)

0.767

No

102(95.3%)

482(94.7%)

 

37(100%)

121(99.2%)

 

Cancer

Yes

0(0%)

5(1)

0.384

0(0%)

0(0%)

-

No

107(100%)

504(99%)

 

37(100%)

122(100%)

 

Osteoporosis

Yes

7(6.5%)

21(4.1%)

0.197

5(13.5%)

10(8.2%)

0.25

No

100(93.5%)

488(95.9%)

 

32(86.5%)

112(91.8%)

 

AS

Yes

1(1%)

2(0.4%)

0.436

0(0%)

1(0.8%)

0.767

No

106(99%)

507(99.6%)

 

37(100%)

121(99.2%)

 

Rheumatoid arthritis

Yes

3(3%)

7(1.4%)

0.244

0(0%)

1(0.8%)

0.767

No

104(97%)

502(98.6%)

 

37(100%)

121(99.2%)

 

Preoperative VAS score

Mean

3.12

3.51

0.131

4.03

3.3

0.081

Cigarette

Yes

17(15.9%)

79(15.5%)

0.5512

4(10.8%)

21(17.2%)

0.255

No

90(84.1%)

430(84.5%)

 

33(89.2%)

101(82.8%)

 
  1. OALL, Ossification of the anterior longitudinal ligament. hs-CRP, Hypersensitive C-reactive protein; BMI, Body Mass Index; CHD, coronary heart disease; AS, Ankylosing spondylitis;
  2. Significant values are in bold.